星期五, 二月 07th, 2014 | Author:

A new treatment that boosts immunity to Epstein-Barr virus may benefit patients with multiple sclerosis, according to the results of an Australian study published in the Multiple Sclerosis Journal.

Category: lymphoma
You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.
Leave a Reply